276 related articles for article (PubMed ID: 18998030)
1. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
2. Body composition in psychotic disorders: a general population survey.
Saarni SE; Saarni SI; Fogelholm M; Heliövaara M; Perälä J; Suvisaari J; Lönnqvist J
Psychol Med; 2009 May; 39(5):801-10. PubMed ID: 18713488
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
[TBL] [Abstract][Full Text] [Related]
4. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
Koga M
Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of obesity and physical inactivity among farmers from Crete (Greece), four decades after the Seven Countries Study.
Vardavas CI; Linardakis MK; Hatzis CM; Saris WH; Kafatos AG
Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):156-62. PubMed ID: 19176283
[TBL] [Abstract][Full Text] [Related]
6. Comparison of body mass index and waist/height ratio in predicting definite coronary artery disease.
Siavash M; Sadeghi M; Salarifar F; Amini M; Shojaee-Moradie F
Ann Nutr Metab; 2008; 53(3-4):162-6. PubMed ID: 19011279
[TBL] [Abstract][Full Text] [Related]
7. [Bodyweight in inpatients with schizophrenia].
Wetterling T; Pest S; Müssigbrodt H; Weber B
Psychiatr Prax; 2004 Jul; 31(5):250-4. PubMed ID: 15243875
[TBL] [Abstract][Full Text] [Related]
8. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
9. Fifteen-year changes in body mass index and waist circumference in Finnish adults.
Lahti-Koski M; Harald K; Männistö S; Laatikainen T; Jousilahti P
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):398-404. PubMed ID: 17568239
[TBL] [Abstract][Full Text] [Related]
10. Comparison of overall obesity and body fat distribution in predicting risk of mortality.
Reis JP; Macera CA; Araneta MR; Lindsay SP; Marshall SJ; Wingard DL
Obesity (Silver Spring); 2009 Jun; 17(6):1232-9. PubMed ID: 19197258
[TBL] [Abstract][Full Text] [Related]
11. Waist circumference and sleep disordered breathing.
Davidson TM; Patel MR
Laryngoscope; 2008 Feb; 118(2):339-47. PubMed ID: 18091340
[TBL] [Abstract][Full Text] [Related]
12. Body mass index, obesity, and psychopathology in patients with schizophrenia.
Subramaniam M; Lam M; Guo ME; He VY; Lee J; Verma S; Chong SA
J Clin Psychopharmacol; 2014 Feb; 34(1):40-6. PubMed ID: 24346756
[TBL] [Abstract][Full Text] [Related]
13. Obesity and smoking in patients with schizophrenia and normal controls: a case-control study.
Fountoulakis KN; Siamouli M; Panagiotidis P; Magiria S; Kantartzis S; Papastergiou N; Shoretsanitis G; Pantoula E; Moutou K; Kouidi E; Deres S
Psychiatry Res; 2010 Mar; 176(1):13-6. PubMed ID: 20079934
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
17. Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus.
Fasanmade OA; Okubadejo NU
Niger J Clin Pract; 2007 Mar; 10(1):52-7. PubMed ID: 17668716
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.
Huang MC; Lu ML; Tsai CJ; Chen PY; Chiu CC; Jian DL; Lin KM; Chen CH
Acta Psychiatr Scand; 2009 Oct; 120(4):274-80. PubMed ID: 19426161
[TBL] [Abstract][Full Text] [Related]
19. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
20. The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study.
Rivenes AC; Harvey SB; Mykletun A
J Psychosom Res; 2009 Apr; 66(4):269-75. PubMed ID: 19302883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
